Hennion & Walsh Asset Management, Inc. Baxter International Inc Transaction History

Hennion & Walsh Asset Management, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 12, 2023	SELL	$49.7 - $57.71 $10,784 - $12,523	-217 Reduced 4.29%	4,839 $247,000
Q3 2022 Nov 14, 2022	SELL	$53.86 - $66.8 $105,673 - $131,061	-1,962 Reduced 27.96%	5,056 $272,000
Q2 2022 Jul 19, 2022	SELL	$63.83 - $80.0 $545,746 - $684,000	-8,550 Reduced 54.92%	7,018 $451,000
Q1 2022 Apr 26, 2022	SELL	$76.85 - $89.45 $614 - $715	-8 Reduced 0.05%	15,568 $1.21 Million
Q4 2021 Feb 14, 2022	SELL	$74.57 - $87.19 $547,045 - $639,625	-7,336 Reduced 32.02%	15,576 $1.34 Million
Q3 2021 Nov 12, 2021	SELL	$73.77 - $83.61 $284,973 - $322,985	-3,863 Reduced 14.43%	22,912 $1.84 Million
Q2 2021 Aug 13, 2021	SELL	$80.5 - $88.01 $673,704 - $736,555	-8,369 Reduced 23.81%	26,775 $2.16 Million
Q1 2021 May 17, 2021	BUY	$76.38 - $86.03 $2.68 Million - $3.02 Million	35,144 New	35,144 $2.96 Million

996

449M

1.97M

3.04M

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $18.2B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

Get notified when there are updates to the investment portfolio of Hennion & Walsh Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Hennion & Walsh Asset Management, Inc. with notifications on news.